Iravani-Saadi Mahdiyar, Karimi Mohammad Hossein, Yaghobi Ramin, Geramizadeh Bita, Ramzi Mani, Niknam Ahmad, Pourfathollah Arefeh
Transplant Research Center, Shiraz University of Medical Sciences , Shiraz , Iran .
Immunol Invest. 2014;43(4):391-404. doi: 10.3109/08820139.2013.879594. Epub 2014 Feb 24.
Costimulatory molecules are important factors determining the outcome of bone marrow transplant. Because the host ability in costimulatory molecule function may be affected by gene polymorphisms, the aim of the present study was to investigate the effect of CTLA4, ICOS, PD.1 and CD28 gene polymorphisms in outcome of bone marrow transplant patients. A total of 72 recipients were included in this study. CTLA4 (-1722, -1661, -318, +49), ICOS (+1720), CD28 (+17) and PD.1 (PD.1.3, PD.1.9) gene polymorphisms were evaluated by PCR-RFLP. The results showed that no differences in the distribution of all mentioned costimulatory molecules genotypes and alleles were observed in the Graft Versus Host Disease (GVHD) group compared to the non-GVHD group. After gender classification, there is a significant association between GA genotype (CTLA4-1661) in male group with GVHD than without GVHD (p=0.03). Also, in this study we found significant associations between CC genotype and C allele of PD.1.9, and TT genotype and T allele of CD28 that had more frequency in grades 2-4 (p=0.04. p=0.02, p=0.01, p=0.003, respectively). Results indicate that the CC genotype and C allele of PD.1.9 and TT genotype and the T allele of CD28 are genetic risk factors for development of a severe grade of GVHD. This subject needs to be studied in different population.
共刺激分子是决定骨髓移植结果的重要因素。由于共刺激分子功能的宿主能力可能受基因多态性影响,本研究旨在探讨CTLA4、ICOS、PD-1和CD28基因多态性对骨髓移植患者预后的影响。本研究共纳入72例受者。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术评估CTLA4(-1722、-1661、-318、+49)、ICOS(+1720)、CD28(+17)和PD-1(PD-1.3、PD-1.9)基因多态性。结果显示,与非移植物抗宿主病(GVHD)组相比,GVHD组中所有提及的共刺激分子基因型和等位基因的分布无差异。按性别分类后,男性组中CTLA4-1661的GA基因型与发生GVHD的相关性显著高于未发生GVHD者(p=0.03)。此外,在本研究中我们发现,PD-1.9的CC基因型和C等位基因,以及CD28的TT基因型和T等位基因在2-4级中频率更高,存在显著相关性(分别为p=0.04、p=0.02、p=0.01、p=0.003)。结果表明,PD-1.9的CC基因型和C等位基因以及CD28的TT基因型和T等位基因是发生严重GVHD的遗传风险因素。这一课题需要在不同人群中进行研究。